Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer

Clinical trial NCT00521781 · TERMINATED

Trial details

NCT number: NCT00521781
Sponsor: The Methodist Hospital Research Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2007-08-01
Primary completion: 2008-09-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.